Preclinical characterization of human Kallikrein 2 (hK2) as a novel target for the treatment of prostate cancer

Authors

• William Kelly

Publication/Presentation Date

1-2024

Volume

42

Issue

4

Published In/Presented At

DOI: 10.1200/JCO.2024.42.4_suppl.202

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

Department(s)

Administration and Leadership

Document Type

Article